Wednesday, March 22, 2023

Health

BIOBIZ: Pfizer’s migraine nasal spray gets FDA approval; Olema Oncology cuts staff by 25%; Ansa Biotechnologies creates world’s longest DNA oligonucleotide; Indaptus doses first...

Pfizer has announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray for the acute treatment of migraine with or without aura in...

Brain Fog caused by Covid-19? Take a Look at Ketones

According to a published scientific study from the Shiraz University of Medical Sciences, two to three months after a covid-19 infection, 20-30% of people who battled the virus may still experience brain fog, which might linger for...

CEO CORNER: Meet Devon Price and Peter Bayne, Co-Founders of VitaNav

In this edition of CEO Corner, we speak with Devon Price and Peter Bayne, Co-Founders, and owners of VitaNav, a functional beverage company, whose main product, Kenetik, is a ketone-based beverage. VitaNav was founded in 2018, and...

BioBiz: Biogen and Eisai Alzheimer’s Drug shows some positive results; New financing for Sudo, Meliora Therapeutics, Kaleidoscope; Daxor test reduces hospital stays

An Alzheimer’s drug that is being developed by Biogen and Eisai is showing some positive results. The newly developed drug that is currently in a phase three trial showed that the experimental monoclonal antibody reduced cognitive decline...

New Study Shows People with Glaucoma are at Significant Risk of Alzheimer’s Disease

A large, nationwide study from Taiwan shows that people with a specific type of glaucoma, called normal-tension glaucoma, are at high risk for developing Alzheimer’s disease. The researchers say people with this type of glaucoma should be screened...

UBC researchers discover ‘weak spot’ across major COVID-19 variants

Researchers at the University of British Columbia have discovered a key vulnerability across all major variants of the SARS-CoV-2 virus, including the recently emerged BA.1 and BA.2 Omicron subvariants. The weakness can be targeted...

Monod Bio Closes $25M Seed Financing to Advance Biosensor Technology Platform

Monod Bio, a life sciences company developing custom diagnostic biosensors that emit light to detect specific biomolecules of interest, has raised a $25M seed financing round. The round was led by Matrix Capital, with participation from the...

Could Loss of Smell from COVID-19 Create Future ‘Dementia Wave’?

A review of studies about the effect of SARS-CoV-2—the virus that causes COVID-19—on the olfactory system introduces questions about whether loss of smell associated with COVID-19 infection may increase the risk of developing dementia later in life. The...

BioBiz: Experimental rectal cancer immunotherapy successful in small study;

A paper in the New England Journal of Medicine describes how an early trial for a drug to treat rectal cancer at Memorial Sloan Kettering Cancer Center, led to remission in every participant. The small trial only...

FDA investigating illnesses linked to Lucky Charms

The Food and Drug Administration is now investigating why hundreds of consumers have reported becoming ill after eating Lucky Charms cereal. At least 139 consumers across the country reported they vomited and had...
- Advertisement -

Latest News

Actress Katherine Heigl’s dog nutrition Brand, BADLANDS RANCH, Sells Over 1 Million Units in less than a year of launch

Badlands Ranch™, founded by actress, animal advocate, and philanthropist Katherine Heigl, has sold over 1 million bags of...
- Advertisement -

Silicon Valley Bank shuts its doors after failing to raise capital

In stunning news of events, Silicon Valley Bank collapsed Friday morning when California regulators closed down the tech lender and put it under...

BIOBIZ: Pfizer’s migraine nasal spray gets FDA approval; Olema Oncology cuts staff by 25%; Ansa Biotechnologies creates world’s longest DNA oligonucleotide; Indaptus doses first...

Pfizer has announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptide (CGRP)...

Americans planning frugal uses for their 2023 tax refunds

Americans likely are receiving smaller tax refunds than they have in recent years, and most people will not be going out to...

The State of Remote Work Three Years After COVID Emptied Offices

The unimaginable happened in March 2020. Many employers shuttered their offices and told their employees to work from home. Today, although office...